MARKET

PPCB

PPCB

Propanc Bio
NASDAQ
0.8393
+0.0143
+1.73%
After Hours: 0.8106 -0.0287 -3.42% 19:48 12/05 EST
OPEN
0.7796
PREV CLOSE
0.8250
HIGH
0.8483
LOW
0.7796
VOLUME
66.15K
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
0.7300
MARKET CAP
11.22M
P/E (TTM)
-0.0185
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 1d ago
Propanc Biopharma Plans To Investigate Phenomenon Of "Mesenchymal Drift" To Help Unlock Chronic Disease Reversal Mechanisms
Benzinga · 2d ago
Propanc Biopharma plans to investigate ‘mesenchymal drift’
TipRanks · 2d ago
Propanc Biopharma Targets Cancer and Fibrosis With Novel PRP Therapy
Reuters · 2d ago
Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs
Barchart · 2d ago
Propanc Biopharma Unveils Patents for Novel Cancer and Fibrosis Treatment
Reuters · 5d ago
Propanc Biopharma requests foreign filing license from Spain
TipRanks · 5d ago
Propanc Biopharma Submits Request For Foreign Filing License From Spain For Two Provisional Patents To Treat Resistant Cancer, Fibrosis
Benzinga · 5d ago
More
About PPCB
Propanc Biopharma, Inc. is an Australia-based biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Webull offers Propanc Biopharma Inc stock information, including NASDAQ: PPCB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPCB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PPCB stock methods without spending real money on the virtual paper trading platform.